Copayment system sees cost of medicines up by over a third
Annual inflation rate rises to 2.2 percent on the back of change in charges for prescription drugs
The introduction of a copayment system for pharmaceuticals in Spain last month saw the cost of medicines for consumers rise by 36.3 percent in July compared to the month before -- an increase that has never before been seen on the statistical data recorded by the National Statistics Institute (INE).
What's more, the rise in the cost of medicines, which went up 22.7 percent in July compared to the same month in 2011, had a huge effect on the general price index (IPC). According to data released on Tuesday by INE, the annual rate of inflation rose to 2.2 percent, which is 0.3 percentage points more than in June.
The copayment system is based on income levels, and for the first time ever obliges Spain's 7.5 million pensioners to pay 10 percent of the cost of their medicines, with a monthly cap of eight, 16 or 60 euros.
In a statement, the Economy Ministry said that annual inflation would have stayed at the 1.9 percent seen in June were it not for this change to the system for medicines.
What's more, the ministry continued, the rise in July corresponds to a "step effect," which will be corrected after 12 months.
According to the INE, as well as the cost of medicines, the cost of transport also rose in July, by 3.8 percent, mostly due to the rise in gas prices. Also on the rise were the costs of home maintenance, which rose 5.4 percent given the higher electricity rates introduced by the government.
Tu suscripción se está usando en otro dispositivo
¿Quieres añadir otro usuario a tu suscripción?
Si continúas leyendo en este dispositivo, no se podrá leer en el otro.
FlechaTu suscripción se está usando en otro dispositivo y solo puedes acceder a EL PAÍS desde un dispositivo a la vez.
Si quieres compartir tu cuenta, cambia tu suscripción a la modalidad Premium, así podrás añadir otro usuario. Cada uno accederá con su propia cuenta de email, lo que os permitirá personalizar vuestra experiencia en EL PAÍS.
¿Tienes una suscripción de empresa? Accede aquí para contratar más cuentas.
En el caso de no saber quién está usando tu cuenta, te recomendamos cambiar tu contraseña aquí.
Si decides continuar compartiendo tu cuenta, este mensaje se mostrará en tu dispositivo y en el de la otra persona que está usando tu cuenta de forma indefinida, afectando a tu experiencia de lectura. Puedes consultar aquí los términos y condiciones de la suscripción digital.
Últimas noticias
More than 40 Democratic lawmakers urge Trump in a letter to stop his ‘attempts to undermine democracy in Brazil’
The journal ‘Science’ criticizes Trump’s anti-renewable energy policy: ‘The US is failing to benefit from its own innovations’
Cubans hope for a miracle as dengue and chikungunya spread
The long shadow of the father figure in the films of Rob Reiner
Most viewed
- Christian Louboutin: ‘Young people don’t want to be like their parents. And if their parents wear sneakers, they’re going to look for something else’
- Cartels in Mexico take a leap forward with narco-drones: ‘It is criminal groups that are leading the innovation race’
- ‘El Limones’ and the growing union disguise of Mexican organized crime
- Liset Menéndez de la Prida, neuroscientist: ‘It’s not normal to constantly seek pleasure; it’s important to be bored, to be calm’
- The low-cost creative revolution: How technology is making art accessible to everyone








































